SentientEdge

Research letters · 14 November 2026

Anthropic (ANT): what the amended S-1 says about the IPO price

This issue

Two weeks ago an analyst said on a podcast that Anthropic could be a $10 trillion company. Last Tuesday the company filed a document that says its own operating margin is about to get worse. Both statements can be true, and the distance between them is the whole question for anyone deciding whether to buy the IPO.

This letter is a departure from our usual format. Instead of new papers, it reads one filing: Amendment No. 2 to Anthropic's Form S-1, filed 10 November 2026, and in particular its Management's Discussion and Analysis. That amendment adds third-quarter results, which the public commentary so far, including the interview that prompted this letter, did not have.

A disclosure belongs at the top. The AI assistant we use to draft these letters is Claude, which Anthropic makes. Every figure below comes from the filing and can be checked there.

1. The claim: "Anthropic is asking Wall Street to believe in AGI"

Nilay Patel interviewing Joey Brookhart of SemiAnalysis · Decoder, The Verge · 29 October 2026 · theverge.com

The argument.

How it holds up against the filing. Better than we expected on the facts, and the filing is less comfortable than the interview on the obligations.

2. What the amended MD&A reports

Anthropic, PBC · Form S-1/A, Amendment No. 2 · filed 10 November 2026 · SEC EDGAR

The offering.

Growth.

QuarterRevenue ($ millions)Change on prior quarterCompute and infrastructure, % of revenueOperating marginAdjusted operating margin
Q1 2025376251%(249)%(221)%
Q2 2025787+109%177%(152)%(129)%
Q3 20251,382+76%148%(224)%(93)%
Q4 20252,040+48%144%(139)%(84)%
Q1 20264,731+132%72%(35)%(13)%
Q2 202611,555+144%48%8%19%
Q3 202616,956+47%58%(3)%15%

Margins.

Commitments.

Cash.

Two smaller disclosures that matter.

Limitations.

Evidence vs speculation.

What the price requires

These are our assumptions, not the filing's.

At $74 the fully diluted value is about $1.3 trillion. After the cash on hand and the offering proceeds, that is about 16 times annualized third-quarter revenue and about 130 times annualized adjusted operating income.

For the shares to return 10% a year for five years, before any further dilution, the company would need to be worth about $2.1 trillion in late 2031. At 25 times earnings that is $83 billion of net income. At a 25% net margin it is about $330 billion of revenue, five times today's run rate, or 38% growth a year for five years.

That is a demanding path, but it is not an AGI path. It is roughly the path the company has already committed to. $451.6 billion due before the end of 2030 averages more than $100 billion a year. If compute stays near half of revenue, paying for that needs revenue of about $200 billion a year on average across the period.

So the buyer at $74 is not being asked to believe in $10 trillion. The buyer is being asked to believe that revenue triples again and then keeps going, on contracts customers can walk away from, while the bills are fixed. If it works, the commitments look like foresight. If growth stalls at two times today's revenue, the same commitments are the problem.

Our view

The business is real: it has customers, gross margin and operating cash flow. The price is defensible, not cheap. The filing itself says the next few quarters will show lower margins as more compute arrives ahead of the revenue it supports.

We would not buy on the first day. Three things make waiting inexpensive. Only about 6% of the shares are being sold, so early trading will reflect scarcity more than value. Every $10 above the midpoint adds about $175 billion to the fully diluted value. And the first two quarterly reports, which will show whether revenue is outrunning the commitments, arrive within about six months.

A small position at or below the range is a reasonable speculation for an investor who can hold through a period of falling margins. A large one, or one bought well above the range, is a bet on the AGI case, and should be sized as such.

What we will do with it. The stock cannot enter our screens until it has a trading history, so we will make no decision at the offering. We will read the first two quarterly reports against three figures from this filing: compute and infrastructure as a share of revenue (58% in the third quarter), revenue growth on the prior quarter (47%), and the amount of short-term compute bought ($5.0 billion). If compute is still above 60% of revenue in the second quarter of 2027, or quarterly growth falls below 15% before annualized revenue reaches $120 billion, we will treat the IPO price as unsupported by the company's own model and say so here.


This letter is drafted with AI research assistance and reviewed and signed by Bob Katz. The assistant used is Claude, a product of Anthropic, the company discussed in this issue. It is research commentary, not investment advice. Figures are taken from Amendment No. 2 to Anthropic's Form S-1 as filed on 10 November 2026; the offering terms can change before pricing. Valuation figures and the five-year arithmetic are our own calculations.